Y10S 435/82
Subcellular parts of microorganisms
Y10S435/82 (Subcellular parts of microorganisms) appears on 141 US grants and 19 published applications in this corpus.
Search patents in Y10S- Granted patents
- 141
- Published applications
- 19
- Assignees
- 91
- Inventors
- 230
- Latest grant
- 24 Feb 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 6 | 0 |
| 1986 | 1 | 0 |
| 1987 | 5 | 0 |
| 1988 | 7 | 0 |
| 1989 | 5 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 10 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 7 | 0 |
| 1998 | 10 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 2 |
| 2002 | 7 | 3 |
| 2003 | 4 | 7 |
| 2004 | 3 | 1 |
| 2005 | 3 | 2 |
| 2006 | 3 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 0 | 1 |
| 2011 | 2 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Device and method for mitochondrial membrane potential assessment24 Feb 2015US 8,961,759 B2The Regents of the University of California
- Protein tyrosine phosphatase substrate-trapping double mutant and uses thereof6 Dec 2011US 8,071,348 B2Albert Einstein College of Medicine of Yeshiva University
- Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)2 Aug 2011US 7,988,956 B2Nektar Therapeutics
- Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)27 Oct 2009US 7,608,253 B2Nektar Therapeutics
- Process for the depletion or removal of endotoxins31 Mar 2009US 7,510,826 B2Qiagen GmbH
- Device and method for mitochondrial membrane potential assessment4 Oct 2012US 2012/0247980 A1The Regents of the University of California
- Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)29 Apr 2010US 2010/0105946 A1Nektar Therapeutics
- Hydrolytically degradable carbamate derivatives of poly (Ethylene Glycol)31 Aug 2006US 2006/0193823 A1Nektar Therapeutics
- Process for the depletion or removal of endotoxins31 Aug 2006US 2006/0194304 A1Qiagen GmbH
- Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)7 Jul 2005US 2005/0147583 A1Nektar Therapeutics AL, Corporation
Most cited
By later US patents
- Method of inserting DNA into living cells359US 4,394,448 A1983
- Process for producing biologically functional molecular chimeras329US 4,237,224 AThe Board of Trustees of the Leland Stanford Jr. University · 1980
- Methods for chromosome-specific staining240US 5,447,841 AThe Regents of the Univ. of California · 1995
- Nucleic acid extraction apparatus224US 6,281,008 B1Toyo Boseki Kabushiki Kaisha · 2001
- Multiple reactor system and method for polynucleotide synthesis155US 4,517,338 AChiron Corporation · 1985